|

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study

RECRUITINGN/ASponsored by Wake Forest University Health Sciences
Actively Recruiting
PhaseN/A
SponsorWake Forest University Health Sciences
Started2024-01-22
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Exercise training in patients with heart failure and preserved ejection fraction (HFpEF) has been associated with an improvement in cardiorespiratory fitness and quality of life.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \> 18
* New York Heart Association (NYHA) Class I-III Heart Failure
* Able to Exercise
* On stable treatment for their cardiac amyloidosis or under active surveillance
* Life expectancy of at least 6 months
* Ability to understand and the willingness to sign a written informed consent document in English, and the willingness/ability to comply with the protocol activities
* Participant must be able and willing to follow the cardiac rehabilitation activities

Exclusion Criteria:

* Inability to provide informed consent
* Inability to commit to in-person supervised exercise sessions for three one-hour sessions a week for 12 weeks
* NYHA Class IV Heart Failure
* Pulmonary disease requiring home oxygen
* Gait instability or history of prior falls
* In the opinion of the Principal Investigator, have a clinically significant comorbid disease that is likely to affect the ability of the patient to complete the trial, interfere with their ability with measurement of self-reported outcomes.

Conditions2

Cardiac AmyloidosisHeart Disease

Locations1 site

Sanger Heart and Vascular Institute
Charlotte, North Carolina, 28204
Dana B Amaro, RN704-355-4692Dana.Amaro@atriumhealth.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.